SMITH LEMLI OPITZ SYNDROME CLINICAL CONSEQUENCES FOR DENTAL CARE ZESPÓŁ SMITH LEMLI OPITZ KONSEKWENCJE KLINICZNE

The Smith-Lemli-Opitz syndrome (SLOS) is a congenital, genetically conditioned, metabolic disorder with autosomal recessive inheritance. The syndrome is caused by high levels of cholesterol precursors, i.e. 7-dyhdrocholesterol (DHCR7) and 8-dehydrocholesterol (DHCR8), which results in cholesterol synthesis disorders. Cholesterol deciency leads to a series of developmental disorders in the foetus and in extreme cases even death. The diagnosis of that congenital metabolic disorder is di€cult due to a diversity of clinical symptoms (there are many mutations of the DHCR7 and DHCR8 genes), which can be exemplied by such cases as that of the 5-year-old boy with SLOS described below. In the presentation the authors have emphasized the problems related to hygienic procedures of the oral cavity and dental treatment, as well as the importance of the early diagnosis of the syndrome and of cooperation with parents. The publication aims at drawing the attention of clinicians to the need of taking SLOS into account in the dierential diagnostics in children.

[1]  C. Ki,et al.  A Novel DHCR7 Mutation in a Smith-Lemli-Opitz Syndrome Infant Presenting with Neonatal Cholestasis , 2009, Journal of Korean medical science.

[2]  G. Pizzo,et al.  Oral manifestations of Smith-Lemli-Opitz syndrome: a paediatric case report. , 2008, European journal of paediatric dentistry.

[3]  X. Estivill,et al.  Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations , 2007, Journal of Medical Genetics.

[4]  R. Steiner,et al.  DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome , 2005, Journal of Medical Genetics.

[5]  K. Muzzin,et al.  Smith-Lemli-Opitz syndrome: a review, case report and dental implications. , 2003, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[6]  D. Chitayat,et al.  Smith-Lemli-Opitz syndrome: carrier frequency and spectrum of DHCR7 mutations in Canada , 2002, Journal of medical genetics.

[7]  U. Seedorf,et al.  Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations , 2001, European Journal of Human Genetics.

[8]  R. Wevers,et al.  Simvastatin: a new therapeutic approach for Smith-Lemli-Opitz syndrome , 2000 .

[9]  R. Kelley,et al.  Inborn errors of cholesterol biosynthesis. , 2003 .

[10]  K. Antoniades,et al.  Craniofacial manifestations of Smith-Lemli-Opitz syndrome: case report. , 1994, International journal of oral and maxillofacial surgery.